Welcome to CDC Stacks | Engineering nanomedicines using stimuli-responsive biomaterials - 33419 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Engineering nanomedicines using stimuli-responsive biomaterials
Filetype[PDF - 4.16 MB]


Details:
  • Personal Authors:
  • Keywords:
  • Pubmed ID:
    22266128
  • Pubmed Central ID:
    PMC3422739
  • Description:
    The ability to engineer particles has the potential to shift the paradigm in the creation of new medicines and diagnostics. Complete control over particle characteristics, such as size, shape, mechanical property, and surface chemistry, can enable rapid translation and facilitate the US Food and Drug Administration (FDA) approval of particle technologies for the treatment of cancer, infectious diseases, diabetes, and a host of other major illnesses. The incorporation of natural and artificial external stimuli to trigger the release of drugs enables exquisite control over the release profiles of drugs in a given environment. In this article, we examine several readily scalable top-down methods for the fabrication of shape-specific particles that utilize stimuli-responsive biomaterials for controlled drug delivery. Special attention is given to Particle Replication In Nonwetting Templates (PRINT®) technology and the application of novel triggered-release synthetic and natural polymers.

  • Document Type:
    Journal Article
  • Collection(s):
    CDC Public Access
  • Funding:
    1DP10D006432-01/DP/NCCDPHP CDC HHS/United States
    1R01EB009565-02/EB/NIBIB NIH HHS/United States
    DP1 CA174425/CA/NCI NIH HHS/United States
    DP1 OD006432/OD/NIH HHS/United States
    R01 EB009565/EB/NIBIB NIH HHS/United States
    R01 U54CA119373/CA/NCI NIH HHS/United States
    U54 CA119343/CA/NCI NIH HHS/United States
    U54 CA151652/CA/NCI NIH HHS/United States
No Related Documents.
You May Also Like:
  1. Multiplex Genome Engineering Using CRISPR/Cas Systems
    Personal Author:
    Cong, Le; Ran, F. Ann; Cox, David; Lin, Shuailiang; Barretto, Robert; Habib, Naomi; Hsu, Patrick D.; Wu, Xuebing; Jiang, Wenyan; Marraffini, Luciano A.; Zhang, Feng;
    Published:
    Jan 03 2013
    Source:
    Science. 339(6121):819-823.
    Description:
    Functional elucidation of causal genetic variants and elements requires precise genome editing technologies. The type II prokaryotic CRISPR (clustered regularly interspaced short palindromic repeats)/Cas adaptive immune system has been shown to facil...
    File Type:
    Filetype[PDF - 287.82 KB]
  2. Genome engineering using the CRISPR-Cas9 system
    Personal Author:
    Ran, F Ann; Hsu, Patrick D; Wright, Jason; Agarwala, Vineeta; Scott, David A; Zhang, Feng;
    Published:
    Oct 24 2013
    Source:
    Nat Protoc. 2013; 8(11):2281-2308.
    Description:
    Targeted nucleases are powerful tools for mediating genome alteration with high precision. The RNA-guided Cas9 nuclease from the microbial clustered regularly interspaced short palindromic repeats (CRISPR) adaptive immune system can be used to facili...
    File Type:
    Filetype[PDF - 1.94 MB]
  3. NIOSH Engineering Controls Program
    Corporate Author:
    National Institute for Occupational Safety and Health.
    Published:
    May 2016
    Series:
    DHHS publication ; no. (NIOSH) 2016-120
    Description:
    The NIOSH Engineering Control Pro- gram seeks to protect workers by en- gineering interventions that can be used to eliminate or more safely work around hazards. This snapshot shows recent accomplishments and upcoming work. : What are our priorities?...
    File Type:
    Filetype[PDF - 280.58 KB]
  4. Engineering controls in healthcare
    Corporate Author:
    National Institute for Occupational Safety and Health. Division of Applied Research and Technology.
    Published:
    September 2012
    Source:
    DHHS publication ; no. (NIOSH) 2012-177
    Series:
    DHHS publication ; no. (NIOSH)
    Description:
    The National Institute for Occupational Safety and Health (NIOSH) conducts research on the control of exposure to infectious aerosols and hazardous drugs in healthcare environments. Research includes: 1. Expedient Airborne Infection Isolation: Public...
    File Type:
    Filetype[PDF - 457.11 KB]
  5. Engineering controls in construction
    Corporate Author:
    National Institute for Occupational Safety and Health. Division of Applied Research and Technology.
    Published:
    September 2012
    Source:
    DHHS publication ; no. (NIOSH) 2012-176
    Series:
    DHHS publication ; no. (NIOSH)
    Description:
    The National Institute for Occupational Safety and Health (NIOSH) has several ongoing research activities focused on the control of hazardous dust and asphalt fumes in the construction industry. These include: Silica in Construction: Workers may be e...
    File Type:
    Filetype[PDF - 581.49 KB]